EMA Begins Publishing Reports on Whether Approved Medicines Still Qualify as Orphans
By Michael Mezher -
Published 17 January 2018
The European Medicines Agency (EMA) on Wednesday announced it has begun publishing reports detailing its decision-making on whether newly approved drugs to treat rare diseases still qualify for orphan designation when they receive marketing authorization.
Categories: News, Europe, EC, EMA, Biologics and biotechnology, Drugs, Orphan products, Submission and registration
Tags: Orphan Medicine Assessment